Electronic Records Enforcement Relaxed During Part 11 Review, FDA Says
This article was originally published in The Tan Sheet
Executive Summary
FDA intends to relax enforcement of its Part 11 regulation on electronic records while it reexamines the rule's application, a 1draft guidance published Feb. 25 states
You may also be interested in...
FDA Will Propose Drug GMP Quality Management Systems By December
FDA expects to release a draft on improving the agency's drug GMP management systems by Dec. 1
Third Party Storage Of Electronic Clinical Data Suggested By PhRMA
FDA should permit electronic storage of clinical data by third parties, the Pharmaceutical Research & Manufacturers of America says in comments on the agency's 1Part 11 electronic records draft guidance
Part 11 guidance withdrawn
FDA guidance on submission of electronic records withdrawn Feb. 3, as it "may no longer represent FDA's approach under the [current good manufacturing practice] initiative." Agency "wishes to limit the time spent by industry" reviewing the guidance, which was published in recent Federal Register (1"The Tan Sheet" Nov. 11, 2002, In Brief). FDA "may decide to reissue the draft guidance once it has reviewed it under the cGMP initiative"...